“The apprehension with making use of non IID detailed ingredients is justified as it is extremely hard to evaluate if FDA would find the ‘novel excipient’ safe for use in a drug merchandise as there isn't any outlined process for evaluation and approval of excipients. The FDA assistance on https://lutherv051rka7.wiki-cms.com/user